Languages: English Español
Currencies:
Use "DIS10" Discount code to get 10% discount on your order. Minimum order amount should be $20.

Medicina Mexico knows that keeping your customers happy, secure and safe is more important than making money and will always result in repeat customers.

By checking your online account, you will see your current and prior orders including your Order Number and any and all payments received. Because our staff is so busy processing orders from all over the world each day, we were forced to make some tough decisions. We are no longer taking phone calls or adding shipping information into the web servers. We do answer all emails within 24 hours and that will never stop.

All order are shipped within 48 hours of receipt of funds unless we are out of stock on a medicine. We are now informing our customers of orders that are out of stock by email. We do not provide tracking numbers unless your order is more than 30 days late beyond all custom delays. PLEASE NOTE: Medicina Mexico has no influence over any government's customs. Access to our shipping computers is no longer available to our English Sections because it resulted in that department failure to finish its daily duties.

Please NOTE: Funds received without an order number or a customer's name are placed into our SUSPENSE ACCOUNT until we are able to determine the correct owner and order number. To avoid this, please always send an email to:  sales@meds.com.mx  along with your order number and the fact that you made a payment.

The UNITED STATES and some other countries require a prescription on all medications sold from Mexico. They further require documentation in English and an invoice of all medicines sold for customs.  For these countries, Medicina Mexico is now delivering your medicines to Dr. Isaac Reyes, MD (Ced. Federal 644884) (Ced. Estatal 1537-02/05) along with the required documentation including documentation on each medication sold in English is from Wolters Kluwer.   Dr. Reyes upon receipt of your medication will issue a prescription and provide for shipping pursuant to your order.  If for any reason, Dr. Reyes fails to issue a prescription for a specific medication, then you will receive a refund or credit.

Please never send an email to more to one of our email addresses and please wait for our response. When sending in an email, please include your full name, and always include your order number and how we can help you. Each day we receive over 90,000 emails and we do not have the time to read repeative emails, nor do we remember prior emails.

Licensed pharmacies in Mexico are only allowed to sell medications, either brands or generics, from an approved pharmaceutical which has passed testing and has subsequently been authorized by the Mexican Government.

Medicina Mexico purchased a 8 million dollar AI System. When a medicine is out of stock, we will now ship the balance of your medicine. The AI will automatically order your medicine and when it arrives it will be shipped to you by our AI System.

Never take a medication without first consulting and getting permission from your MD.

If you look on the left-hand side of any of our web pages at (About US) you will see our licenses, permits and our Regulatory Body.

PLEASE TAKE NOTICE: Our email address is:  sales@meds.com.mx or meds.com.mx@gmail.com.

   
   
Manufacturers
Quick Find
 
Use keywords to find the product you are looking for.
Advanced Search

Depakene 250mg 60 Caps, Valproic Acid

Depakene 250mg 60 Caps, Valproic Acid
Model:7501033920332
Current Reviews:0
Price:$38.50

THIS IS A BRAND MEDICATION

THERAPEUTIC INDICATIONS: Anticonvulsant.

Epilepsy: DEPAKENE and cover the whole therapeutic spectrum of epileptic seizures in adults and children 10 years of age and older. In children under 10 years of age should be cautious of high risk of hepatotoxicity and hyperammonemic encephalopathy should be altered in the urea cycle.

DEPAKENE are indicated in patients with simple and complex partial seizures that occur in isolation or associated with another type of crisis, as monotherapy or added.

DEPAKENE and are indicated as monotherapy or therapy for the treatment of generalized seizures, absence seizures as simple or complex, tonic, clonic, myoclonic and grand mal seizures. In addition to epileptic syndromes.

Migraine:DEPAKENE Tablets is indicated for the prophylaxis of migraine headaches with aura or without aura, and to reduce the number of episodes or the severity of the crisis.

Mood Disorder: It is a heterogeneous group of diseases, typically recurrent, which includes unipolar disorder (depression) and bipolar (manic-depressive). It consists of mood disorders with infiltrative nature, which are accompanied by vegetative symptoms and psychomotor dysfunction.

DEPAKENE are indicated in the treatment of bipolar disorder in acute manic episode and mixed episodes associated with bipolar disorder, with or without psychotic features.

In the mood disorder is Inlcudes bipolar spectrum disorder, within which is the manic episode, which is an abnormal state of mind which is characterized by a state of persistently elevated mood, expansive and irritable. Also, mixed episode is characterized by gathering the diagnostic criteria for a manic episode and major depressive episode.

CONTRAINDICATIONS: Valproate semisodium or other valproate should not be administered to patients with liver disease or significant hepatic dysfunction. Is contraindicated in patients with known hypersensitivity to the drug, and / or changes in the urea cycle.

The concentration of valproate in the cerebrospinal fluid approaches the free concentration in plasma (about 10% of the total concentration). Therefore, patients taking enzyme-inducing antiepileptic drugs (carbamazepine, phenytoin and phenobarbital) should be monitored, and that will clear valproate quickly. Because of this, monitoring of antiepileptic concentrations should be intensified whenever concomitant antiepileptics increase or withdrawn.

The relationship between plasma concentration and clinical response is not well documented. One contributing factor is the nonlinear concentration-dependent protein binding of valproate, which affects drug clearance.

Liver disease impairs the ability to eliminate valproate. The clearance of free valproate in renal patients has been reported is slightly decreased, although it seems that there is no need to adjust the dose of valproate.

The therapeutic range in epilepsy is commonly considered 50 to 100 mg / ml of total valproate, although some patients can be controlled with lower or higher plasma concentrations. In controlled clinical research with placebo in acute mania patients had clinical response with plasma concentrations between 50 and 135 mg / ml.

Caution should be exercised when administering valproate DEPAKENE or any other patients with a history of liver disease, patients with severe epilepsy accompanied by mental retardation and those with organic brain disease, since there have been changes in liver function, including failure with fatal results in some patients receiving valproic acid. This has occurred during the first six months of treatment. Severe or fatal hepatotoxicity may be preceded by nonspecific symptoms such as loss of seizure control, malaise, weakness, lethargy, facial edema, anorexia and vomiting. In patients with epilepsy may occur a loss of seizure control. It should be tested for liver function before starting treatment and at frequent intervals thereafter, especially during the first six months.

However, should not rely entirely on the functional tests (blood chemistry), since they may not be abnormal in all cases, therefore, be considered the results of a thorough medical examination, carried out periodically.

Caution must be used when administering valproate semisodium patients with a history of liver disease with multiple anticonvulsants, children with congenital metabolic disorders, those with severe seizure disorders accompanied by mental retardation and organic brain disease.

Experience has shown that children under two years are at greater risk of developing fatal hepatotoxicity, its use at this age should be done with extreme caution and as a single drug. The benefit of seizure control should be calculated against the risk. In older patients, the incidence of fatal hepatotoxicity decreases.

In the pediatric population is only recommended for children 10 years of age and older.

The drug should be discontinued immediately in the presence of liver dysfunction. In some cases, hepatic dysfunction has progressed despite discontinuation of the drug.

The frequency of adverse effects (particularly elevated liver enzymes and thrombocytopenia) may be dependent on the dose. The benefit of treatment to improve seizure control, which accompany the use of higher doses should be weighed against the possibility of higher incidence of adverse effects.


DOSAGE AND ADMINISTRATION: Depakene (valproic acid) is administered orally. The recommended starting dose in both children and adults is 15 mg / kg / day until seizure controlor side-effects that prevent further increases. The maximum recommended dose is 60 mg / kg/ day in divided doses. If the total dose is greater than 250 mg should be administered alsofractionated.

Initial dose: 15 mg / kg / day.

Dose adjustment: 5 to 10 mg / kg / day.

Maximum dose: 60 mg / kg / day ..

Medication name: Depakene
Comparable patent medicine: Depakene
Active ingredient: Valproic Acid
Presentation: Tablets
Concentration: 250 mg
Extended-release tablets: No
Lab: Abbott Laboratories de Mexico, SA de CV
box 60 tab
Made in: Mexico

   
   
   
Shopping Cart:
now in your cart 0 items
   
Manufacturer Info
Share Product
Share on Digg Share via E-Mail
Share on Twitter